GOLGA6L6 | Golgin A6 family-like 6 | | | | | | Tissue enriched |
POTEB2 | POTE ankyrin domain family, member B2 | | | | | | Tissue enriched |
POTEB | POTE ankyrin domain family, member B | | | | | | Tissue enriched |
OR4M2 | Olfactory receptor, family 4, subfamily M, member 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR4N4 | Olfactory receptor, family 4, subfamily N, member 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
GOLGA6L1 | Golgin A6 family-like 1 | | | | | | Tissue enriched |
TUBGCP5 | Tubulin, gamma complex associated protein 5 | | | | | | Expressed in all |
NIPA1 | Non imprinted in Prader-Willi/Angelman syndrome 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
GOLGA8I | Golgin A8 family, member I | | | | | | Mixed |
RP11-467N20.5 | Protein LOC440233 | | | | | | Tissue enriched |
GOLGA8S | Golgin A8 family, member S | | | | | | Tissue enhanced |
GOLGA6L2 | Golgin A6 family-like 2 | | | | | | Tissue enriched |
MKRN3 | Makorin ring finger protein 3 | Disease related genes
| | | | | Tissue enhanced |
NPAP1 | Nuclear pore associated protein 1 | | | | | | Tissue enriched |
SNRPN | Small nuclear ribonucleoprotein polypeptide N | Plasma proteins
| | | | | Expressed in all |
UBE3A | Ubiquitin protein ligase E3A | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ATP10A | ATPase, class V, type 10A | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
GABRG3 | Gamma-aminobutyric acid (GABA) A receptor, gamma 3 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OCA2 | Oculocutaneous albinism II | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HERC2 | HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
GOLGA8M | Golgin A8 family, member M | | | | | | Tissue enhanced |
APBA2 | Amyloid beta (A4) precursor protein-binding, family A, member 2 | | | | | | Tissue enhanced |
FAM189A1 | Family with sequence similarity 189, member A1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TJP1 | Tight junction protein 1 | | | | | | Mixed |
GOLGA8J | Golgin A8 family, member J | | | | | | Tissue enhanced |
GOLGA8T | Golgin A8 family, member T | | | | | | Tissue enhanced |
GOLGA8R | Golgin A8 family, member R | | | | | | Tissue enhanced |
GOLGA8Q | Golgin A8 family, member Q | | | | | | Tissue enhanced |
GOLGA8H | Golgin A8 family, member H | | | | | | Tissue enhanced |
ARHGAP11B | Rho GTPase activating protein 11B | | | | | | Mixed |
FAN1 | FANCD2/FANCI-associated nuclease 1 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
MTMR10 | Myotubularin related protein 10 | | | | | | Expressed in all |
TRPM1 | Transient receptor potential cation channel, subfamily M, member 1 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KLF13 | Kruppel-like factor 13 | Plasma proteins Transcription factors
| | | | | Expressed in all |
OTUD7A | OTU domain containing 7A | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CHRNA7 | Cholinergic receptor, nicotinic, alpha 7 (neuronal) | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
GOLGA8K | Golgin A8 family, member K | | | | | | Tissue enhanced |
AC139426.2 | Uncharacterized protein; cDNA FLJ52611 | | | | | | Not detected |
GOLGA8O | Golgin A8 family, member O | | | | | | Tissue enhanced |
GOLGA8N | Golgin A8 family, member N | | | | | | Expressed in all |
ARHGAP11A | Rho GTPase activating protein 11A | | | | | | Mixed |
SCG5 | Secretogranin V (7B2 protein) | Predicted secreted proteins
| | | | | Tissue enhanced |
GREM1 | Gremlin 1, DAN family BMP antagonist | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
FMN1 | Formin 1 | | | | | | Mixed |
RYR3 | Ryanodine receptor 3 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AVEN | Apoptosis, caspase activation inhibitor | | | | | | Expressed in all |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
EMC7 | ER membrane protein complex subunit 7 | Predicted membrane proteins
| | | | | Expressed in all |
PGBD4 | PiggyBac transposable element derived 4 | | | | | | Mixed |
KATNBL1 | Katanin p80 subunit B-like 1 | | | | | | Expressed in all |